Selected Companies

The below companies have been selected for presentation at the Biotech & Finance Forum:

Zvia Agur

Ph.D., Chairperson and CSO

Optimata Ltd. (Israel)

Wolfgang Albrecht

c-a-i-r biosciences GmbH (Germany)

Matteo Bonacina

proMEV s.r.l. (Italy)

Remi Delansorne

Hybrigenics (France)

Suzanne Dilly

CEO

Tangent Reprofiling Limited (United Kingdom)

Patrck Doyle

Syntaxin Ltd (United Kingdom)

Jean Baptiste Dumas Milne Edwards

Helios BioSciences (France)

Christopher Dyer

Sci-Mate (Germany)

Florian Fischer

Affimed Therapeutics (Germany)

Ilona Funke

Chief Medical Officer / Managing Director

SpheroTec GmbH (Germany)

Francesco Girardo

BioMan Srl (Italy)

Richard Godfrey

Balter Medical AS (Norway)

Andreas Grassauer

Marinomed Biotechnologie GmbH (Austria)

Raimo Harju

CEO

Vactech Ltd. (Finland)

Rainer Henning

Fibrex Medical Research & Development GmbH (Austria)

Edith Huland

Founder

Immunservice GmbH (Germany)

Alistair Hurst

Chemel AB (Sweden)

Nora Kaarela

Ipsat Therapies (Finland)

Krzysztof Kucharczyk

BioVectis (Poland)

Klaus Lang

LANG Industrieservice GmbH (Germany)

Gabriele Marmieri

Biomat srl (Italy)

Wolfgang Mutter

Profos Diagnostics AG (Germany)

Peter Pack

mtm laboratories (Germany)

Christian Palme

mNEMOSCIENCE GmbH (Germany)

Thomas Radtke

Cardiobridge (Germany)

Andrea Reinhardt

microTEC (Germany)

Patrick J. Rousseau

ValiBio SA (Belgium)

Tristan Rousselle

Protein eXpert SA (France)

Heinz Schwer

Sloning BioTechnology (Germany)

Jack Spira

Oncopeptides AB (Sweden)

Petr Stehlicek

of the Board

Bio-Skin, a.s. (Czech Republic)

Thomas Taapken

elbion (Belgium)

Anne Thews

Cofounder

Curetis AG (Germany)

Michael Tysiak

CEO & CFO

BIOBASE GmbH (Germany)

Bart Van de Vyver

SpinX Technologies (Switzerland)

Martin Waleij

Dignitana AB (Sweden)